Biblio

Export 1939 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is B  [Clear All Filters]
2016
A. Jacquin-Piques, Sacco, G., Tavassoli, N., Rouaud, O., Bejot, Y., Giroud, M., Robert, P., Vellas, B., and Bonin-Guillaume, S., “Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.”, J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
A. Jacquin-Piques, Sacco, G., Tavassoli, N., Rouaud, O., Bejot, Y., Giroud, M., Robert, P., Vellas, B., and Bonin-Guillaume, S., “Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.”, J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
X. - P. Hong, Chen, T., Yin, N. - N., Han, Y. - M., Yuan, F., Duan, Y. - J., Shen, F., Zhang, Y. - H., and Bin Chen, Z. -, “Puerarin Ameliorates D-Galactose Induced Enhanced Hippocampal Neurogenesis and Tau Hyperphosphorylation in Rat Brain.”, J Alzheimers Dis, vol. 51, no. 2, pp. 605-17, 2016.
X. Bengoetxea, de Cerain, A. López, Azqueta, A., and Ramirez, M. J., “Purported Interactions of Amyloid-β and Glucocorticoids in Cytotoxicity and Genotoxicity: Implications in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1085-1094, 2016.
M. Maxime Lavallée, Gandini, D., Rouleau, I., Vallet, G. T., Joannette, M., Kergoat, M. - J., Busigny, T., Rossion, B., and Joubert, S., “A Qualitative Impairment in Face Perception in Alzheimer's Disease: Evidence from a Reduced Face Inversion Effect.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1225-36, 2016.
J. Ahdidan, Raji, C. A., DeYoe, E. A., Mathis, J., Noe, K. Ø., Rimestad, J., Kjeldsen, T. K., Mosegaard, J., Becker, J. T., and Lopez, O., “Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging.”, J Alzheimers Dis, vol. 49, no. 3, pp. 723-32, 2016.
J. C. Triplett, Swomley, A. M., Cai, J., Klein, J. B., and D Butterfield, A., “Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 45-62, 2016.
J. Carlos Cej Bolívar and Saladie, D. Gil, “Redefining Amnestic Mild Cognitive Impairment as an Early Form of Alzheimer's Disease Based on Assessment of Memory Systems.”, J Alzheimers Dis, vol. 53, no. 2, pp. 705-12, 2016.
S. Tholen, Schmaderer, C., Chmielewski, S., Förstl, H., Heemann, U., Baumann, M., Steubl, D., and Grimmer, T., “Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?”, J Alzheimers Dis, vol. 50, no. 3, pp. 791-6, 2016.
I. Cuchillo-Ibañez, Balmaceda, V., Mata-Balaguer, T., Lopez-Font, I., and Sáez-Valero, J., “Reelin in Alzheimer's Disease, Increased Levels but Impaired Signaling: When More is Less.”, J Alzheimers Dis, vol. 52, no. 2, pp. 403-16, 2016.
W. Gomm, von Holt, K., Thomé, F., Broich, K., Maier, W., Weckbecker, K., Fink, A., Doblhammer, G., and Haenisch, B., “Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data.”, J Alzheimers Dis, vol. 54, no. 2, pp. 801-8, 2016.
C. A. Myers, Keller, J. N., H Allen, R., Brouillette, R. M., Foil, H., Davis, A. B., Greenway, F. L., Johnson, W. D., and Martin, C. K., “Reliability and Validity of a Novel Internet-Based Battery to Assess Mood and Cognitive Function in the Elderly.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1359-1364, 2016.
A. Bryndis Einarsdottir, Hardarson, S. Hakon, Kristjansdottir, J. Valgerdur, Bragason, D. Thor, Snaedal, J., and Stefánsson, E., “Retinal oximetry imaging in Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 79-83, 2016.
S. Salomon-Zimri, Glat, M. Johanna, Barhum, Y., Luz, I., Boehm-Cagan, A., Liraz, O., Ben-Zur, T., Offen, D., and Michaelson, D. M., “Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1443-58, 2016.
S. Salomon-Zimri, Glat, M. Johanna, Barhum, Y., Luz, I., Boehm-Cagan, A., Liraz, O., Ben-Zur, T., Offen, D., and Michaelson, D. M., “Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1443-58, 2016.
S. Salomon-Zimri, Glat, M. Johanna, Barhum, Y., Luz, I., Boehm-Cagan, A., Liraz, O., Ben-Zur, T., Offen, D., and Michaelson, D. M., “Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1443-58, 2016.
G. Koch, Di Lorenzo, F., Del Olmo, M. Fernandez, Bonní, S., Ponzo, V., Caltagirone, C., Bozzali, M., and Martorana, A., “Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression.”, J Alzheimers Dis, vol. 50, no. 2, pp. 605-16, 2016.
G. Koch, Di Lorenzo, F., Del Olmo, M. Fernandez, Bonní, S., Ponzo, V., Caltagirone, C., Bozzali, M., and Martorana, A., “Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression.”, J Alzheimers Dis, vol. 50, no. 2, pp. 605-16, 2016.
S. Baiardi, Capellari, S., Ladogana, A., Strumia, S., Santangelo, M., Pocchiari, M., and Parchi, P., “Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings.”, J Alzheimers Dis, vol. 50, no. 2, pp. 465-76, 2016.
I. Beheshti, Olya, H. G. T., and Demirel, H., “Risk Assessment of Alzheimer's Disease using the Information Diffusion Model from Structural Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1335-42, 2016.
B. E. Gavett, John, S. E., Gurnani, A. S., Bussell, C. A., and Saurman, J. L., “The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 531-45, 2016.
A. Shelef, Barak, Y., Berger, U., Paleacu, D., Tadger, S., Plopsky, I., and Baruch, Y., “Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.”, J Alzheimers Dis, vol. 51, no. 1, pp. 15-9, 2016.
A. Shelef, Barak, Y., Berger, U., Paleacu, D., Tadger, S., Plopsky, I., and Baruch, Y., “Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.”, J Alzheimers Dis, vol. 51, no. 1, pp. 15-9, 2016.
A. Shelef, Barak, Y., Berger, U., Paleacu, D., Tadger, S., Plopsky, I., and Baruch, Y., “Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.”, J Alzheimers Dis, vol. 51, no. 1, pp. 15-9, 2016.
J. Bennett, Burns, J., Welch, P., and Bothwell, R., “Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1179-87, 2016.

Pages